Contemporary hormone therapy with LHRH agonists for prostate cancer: avoiding osteoporosis and fracture

INTRODUCTION: Prostate cancer is a large clinical burden across Europe. It is, in fact, the most common cancer in males, accounting for more than 92,300 deaths annually throughout the continent. Prostate cancer is androgen-sensitive; thus an androgen deprivation therapy (ADT) is often used for treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Hannah C.P., Shah, Syed I.A., Abel, Paul D., Price, Patricia, Honeyfield, Lesley, Edwards, Steve, Abel, Richard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2015
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526606/
https://www.ncbi.nlm.nih.gov/pubmed/26251735
http://dx.doi.org/10.5173/ceju.2015.513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526606/
https://www.ncbi.nlm.nih.gov/pubmed/26251735
http://dx.doi.org/10.5173/ceju.2015.513

Ejemplares similares